These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31511186)

  • 21. The complex interface between economy and healthcare: An introductory overview for clinicians.
    Ottolini FL; Buggio L; Somigliana E; Vercellini P
    Eur J Intern Med; 2016 Dec; 36():1-6. PubMed ID: 27577606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Payer perceptions and use of value assessment tools in the United States.
    Westrich K; Hydery T; Dharbhamalla V; Buelt L; Zheng C; Loo V; Graff J
    J Manag Care Spec Pharm; 2023 May; 29(5):582-588. PubMed ID: 37121246
    [No Abstract]   [Full Text] [Related]  

  • 23. How to develop cost-conscious guidelines.
    Eccles M; Mason J
    Health Technol Assess; 2001; 5(16):1-69. PubMed ID: 11427188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why Value Framework Assessments Arrive at Different Conclusions: A Multiple Myeloma Case Study.
    Westrich K; Buelt L; Dubois RW
    J Manag Care Spec Pharm; 2017 Jun; 23(6-a Suppl):S28-S33. PubMed ID: 28535102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value Project.
    Jansen JP; Incerti D; Linthicum MT
    Pharmacoeconomics; 2019 Nov; 37(11):1313-1320. PubMed ID: 31392665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining and Measuring the Affordability of New Medicines: A Systematic Review.
    Antoñanzas F; Terkola R; Overton PM; Shalet N; Postma M
    Pharmacoeconomics; 2017 Aug; 35(8):777-791. PubMed ID: 28477220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining Elements of Value in Health Care-A Health Economics Approach: An ISPOR Special Task Force Report [3].
    Lakdawalla DN; Doshi JA; Garrison LP; Phelps CE; Basu A; Danzon PM
    Value Health; 2018 Feb; 21(2):131-139. PubMed ID: 29477390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet?
    Vass CM; Payne K
    Pharmacoeconomics; 2017 Sep; 35(9):859-866. PubMed ID: 28536955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Philosophical concerns regarding cost-effectiveness analyses.
    Weiner BK
    Med Hypotheses; 2010 Feb; 74(2):383-6. PubMed ID: 19651478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporating health equity into value assessment: frameworks, promising alternatives, and future directions.
    Diaby V; Ali A; Babcock A; Fuhr J; Braithwaite D
    J Manag Care Spec Pharm; 2021 Sep; 27(9-a Suppl):S22-S29. PubMed ID: 34579542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic evaluation of interventions in health care.
    McFarland A
    Nurs Stand; 2014 Nov; 29(10):49-58. PubMed ID: 25370268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing value in health care: using an interpretive classification system to understand existing practices based on a systematic review.
    Seixas BV; Dionne F; Conte T; Mitton C
    BMC Health Serv Res; 2019 Aug; 19(1):560. PubMed ID: 31409369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Framework for Measuring Low-Value Care.
    Miller G; Rhyan C; Beaudin-Seiler B; Hughes-Cromwick P
    Value Health; 2018 Apr; 21(4):375-379. PubMed ID: 29680091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What Is Value in Health and Healthcare? A Systematic Literature Review of Value Assessment Frameworks.
    Zhang M; Bao Y; Lang Y; Fu S; Kimber M; Levine M; Xie F
    Value Health; 2022 Feb; 25(2):302-317. PubMed ID: 35094803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare.
    Jönsson B; Hampson G; Michaels J; Towse A; von der Schulenburg JG; Wong O
    Eur J Health Econ; 2019 Apr; 20(3):427-438. PubMed ID: 30229376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DEVELOPMENTS IN VALUE FRAMEWORKS TO INFORM THE ALLOCATION OF HEALTHCARE RESOURCES.
    Oortwijn W; Sampietro-Colom L; Habens F
    Int J Technol Assess Health Care; 2017 Jan; 33(2):323-329. PubMed ID: 28578735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
    Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
    Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adapting Economic Evaluation Methods to Shifting Global Health Priorities: Assessing the Value of Health System Inputs.
    McGuire F; Mohan S; Walker S; Nabyonga-Orem J; Ssengooba F; Kataika E; Revill P
    Value Health Reg Issues; 2024 Jan; 39():31-39. PubMed ID: 37976775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incorporating Affordability Concerns Within Cost-Effectiveness Analysis for Health Technology Assessment.
    Lomas JRS
    Value Health; 2019 Aug; 22(8):898-905. PubMed ID: 31426931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.